Tag: drug delivery devices market outlook

  • Drug Delivery Devices Market Performance and Future Outlook at 6.2% CAGR Through 2029

    Drug Delivery Devices Market Performance and Future Outlook at 6.2% CAGR Through 2029

    Uncover key drivers, emerging technologies, and competitive movements shaping the drug delivery devices market from 2025–2034 with trusted insights from The Business Research Company

    What Is The Predicted Size Of The Drug Delivery Devices Industry By 2029?

    The drug delivery devices market size has demonstrated robust growth in recent years. It is projected to expand from $91.03 billion in 2024 to $95.99 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.4%. The historical growth of this market can be ascribed to several factors, including the swift increase in the elderly population, the expansion in the number of healthcare facilities, economic development in emerging markets, and increased healthcare expenditure.

    The drug delivery devices market is projected to experience substantial expansion in the coming years, reaching $122.16 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.2%. This projected growth during the forecast period is primarily driven by factors such as the rising incidence of chronic diseases, a growing need for injectables, an escalating demand for drug delivery devices themselves, and the unexpected appearance of severe infections. Key trends anticipated during this period involve significant investment in microneedle drug technology for delivery, extensive research and development into self-injectable drug delivery solutions, a strategic emphasis on mergers and acquisitions, and an increased focus on wearable drug delivery devices.

    Access A Free Sample Of The Report:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

    What Major Drivers Are Impacting The Drug Delivery Devices Market?

    The drug delivery devices market is anticipated to be propelled by the growing incidence of chronic conditions such as cardiovascular diseases, diabetes, cancer, and other illnesses. For instance, in January 2023, according to the National Library of Medicine, a US-based medical library operated by the federal government, the number of individuals in the United States aged 50 and older with at least one chronic condition is projected to increase by 99.5%. This increase would see the number rise from 71.522 million in 2020 to 142.66 million by 2050. Medical drugs can be administered through various routes, and the development of new drug delivery systems plays a major role in the pharmaceutical industry. Global research and development (R&D) in drug delivery is expanding due to the increasing prevalence of these diseases. Most pharmaceutical companies are focusing on multiple drug delivery technologies to create significant advantages and better outcomes for their marketed products. Hence, the increasing prevalence of chronic diseases is leading to increased consumption of therapeutic drugs and therapies, and this factor is expected to drive the growth of the drug delivery devices market.

    Which Segment Categories Are Driving Maximum Growth In The Drug Delivery Devices Market?

    The drug delivery devicesmarket covered in this report is segmented –

    1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

    2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

    3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

    Subsegments:

    1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

    2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

    3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

    4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

    5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

    6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

    7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

    8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

    Which Long-Term Trends Will Play A Crucial Role In The Drug Delivery Devices Market?

    Major companies operating in the drug delivery device market are concentrating on creating innovative devices like autoinjectors with completely built-in connectivity to gain a competitive edge. Autoinjectors are medical instruments designed for the self-administration of a pre-measured dose of medication. For instance, in May 2022, Jabil Healthcare, a US-based provider of healthcare manufacturing solutions, unveiled the Qfinity autoinjector platform, a reusable drug delivery device. The Qfinity autoinjector platform stands out as a simple, reusable, and modular solution for subcutaneous drug self-administration, providing a cost-effective alternative to market competitors while promoting sustainable drug delivery in the pharmaceutical industry. With its versatile design, it can handle various drug volumes and viscosities, featuring a patient-centric form factor that offers up to 65% lower cost per injection compared to leading disposable autoinjectors. The robust Qfinity device supports over 100 injections and uses 1 mL or 2.25 mL pre-filled disposable cassettes. Additionally, its optimized component and material usage results in an estimated 65% decrease in cost per injection, a 60% smaller carbon footprint, a 50% reduction in manufacturing footprint, and a 70% decrease in capital expenditure (CAPEX).

    Who Are The Dominant Players In The Drug Delivery Devices Market Today?

    Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

    Download The Full Report Here:

    https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

    Which Region Is At The Forefront Of Innovation In The Drug Delivery Devices Market?

    North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Get A Report Customized For You Here:

    https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

    Browse Through More Reports Similar to the Global Drug Delivery Devices Market 2025, By The Business Research Company

    Implantable Drug Delivery Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

    Injectable Drug Delivery Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

    Liposomal Drug Delivery Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Drug Delivery Devices Market Forecast 2025–2034: Where Businesses Should Invest Next

    Drug Delivery Devices Market Forecast 2025–2034: Where Businesses Should Invest Next

    Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

    What Is The Predicted Market Size Trajectory For The Drug Delivery Devices Market From 2025 To 2034?

    The domain of drug delivery devices has witnessed robust expansion lately, with its valuation projected to advance from $91.03 billion in 2024 to $95.99 billion the following year, reflecting a consistent compound annual growth rate of 5.4%; this upward trajectory during the past period stems from several factors, notably the swift increase in the senior population demographic, the proliferation of medical treatment centers, economic development taking root in developing economies, and amplified spending allocated to healthcare services.

    Anticipating robust expansion, the market associated with drug delivery apparatuses is projected to attain a valuation of $122.16 billion by 2029, reflecting a compound annual growth rate of 6.2% throughout the ensuing period; this surge is fundamentally driven by the rising incidence of long-term ailments, a heightened need for injectable pharmaceuticals, greater overall requirement for drug administration systems, and the unforeseen outbreak of serious infectious conditions; furthermore, pivotal shifts influencing this market during the projection timeframe involve substantial allocations toward microneedle-based drug administration advancements, ongoing investigations into self-administering injection tools, a strategic emphasis on consolidation through corporate buyouts and mergers, alongside considerable investment directed towards developing wearable drug delivery technologies.

    Unlock Your Free Sample Report for Exclusive Market Data:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

    What Are The Key Drivers Of Growth In The Drug Delivery Devices Market?

    The expanding incidence of long-term ailments, encompassing conditions such as heart disease, diabetes, malignancies, and further illnesses, is anticipated to be a principal impetus for the expansion of the drug delivery devices sector; for illustration, data from the National Library of Medicine, a US federal medical repository, indicated in January 2023 that the population aged fifty and above in the United States suffering from a minimum of one chronic ailment is forecast to double, escalating from 71.522 million in the year 2020 to 142.66 million by the year 2050. Considering the diverse avenues available for introducing medical substances into the body, novel drug administration technologies are becoming significantly important within the pharmaceutical realm, prompting heightened global research and development efforts correlative to the escalating frequency of these health issues; consequently, numerous pharmaceutical entities are concentrating resources on various drug conveyance methods aiming to secure superior competitive edges and enhanced efficacy for their commercialized pharmaceuticals, thus, the mounting occurrence of chronic conditions directly translates to greater utilization of medicinal treatments, which serves as a propelling force for the ascending trajectory of the drug delivery devices market.

    What Are The Leading Segments Analyzed In The Drug Delivery Devices Market?

    The drug delivery devicesmarket covered in this report is segmented –

    1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery

    2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings

    3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

    Subsegments:

    1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets

    2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps

    3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders

    4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems

    5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers

    6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops

    7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films

    8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

    Which Key Trends Are Expected To Influence The Drug Delivery Devices Market In The Coming Years?

    Key players within the drug delivery device sector are concentrating their efforts on creating cutting-edge apparatus, specifically internet-connected autoinjectors, aiming to secure a stronger market position. These autoinjectors are medical instruments engineered to allow patients to inject a predetermined amount of medicine themselves. To illustrate, a significant development occurred in May 2022 when Jabil Healthcare, a US entity specializing in healthcare manufacturing services, introduced the Qfinity autoinjector system, which is a drug delivery mechanism intended for repeated use. Distinguished by its simplicity, modularity, and reusability for subcutaneous self-injection, the Qfinity platform presents an economical substitute against existing market options, simultaneously championing environmentally conscious drug administration across the pharmaceutical landscape. Its adaptable structure accommodates a range of drug volumes and thicknesses, presenting a design centered around the user that delivers savings up to 65 percent in the cost per injection when contrasted with top disposable autoinjectors. Furthermore, this robust Qfinity instrument is capable of facilitating more than a hundred injections and is compatible with drug cartridges that are pre-filled and disposable, either in 1 mL or 2.25 mL sizes. The reduced consumption of materials and components consequently yields substantial environmental and economic benefits, estimated to include a 65 percent lowering in the expense per injection, a 60 percent smaller environmental impact, a 50 percent reduction in the factory footprint required for production, and a 70 percent drop in necessary initial investment spending.

    Who Are The Key Multinational Companies Dominating The Drug Delivery Devices Market?

    Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

    Download The Full Report For Exclusive Market Findings:

    https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

    What Are The Regional Market Dynamics Impacting The Drug Delivery Devices Industry?

    North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Request A Customized Version Of The Drug Delivery Devices Market Report:

    https://www.thebusinessresearchcompany.com/customise?id=2833&type=smp

    Browse Through More Reports Similar to the Global Drug Delivery Devices Market 2025, By The Business Research Company

    Implantable Drug Delivery Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

    Injectable Drug Delivery Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

    Liposomal Drug Delivery Devices Global Market Report 2025

    https://www.thebusinessresearchcompany.com/report/liposomal-drug-delivery-devices-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model